Skip to main content

StoryCatch Partners Acquires EmpiraMed

Combined organization will unlock patterns in complex participant populations, driving physical and mental health improvement WELLESLEY HILLS, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) — StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that it has acquired Maynard, Mass.-based EmpiraMed Inc., a digital health technology leader in the field of virtual clinical studies for real-world evidence. EmpiraMed performs post-market, prospective, virtual clinical studies to generate real-world evidence for life sciences, pioneering site-less virtual studies. Its software helps clients produce evidence for expanding market access, deploy patient-centered rare disease registries, and support faster regulatory approval of new indications and label...

Continue reading

Apica Acquires Orson to Transform Enterprise Test Data Management

STOCKHOLM and EL SEGUNDO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) —  Apica, the intelligent data management platform, today announced the acquisition of Orson, an innovative test data orchestration platform. This strategic acquisition strengthens Apica’s position in the DevOps marketplace by combining industry-leading synthetic monitoring capabilities with advanced test data orchestration, enabling organizations to build more robust monitoring scenarios through accelerated data variety generation. The acquisition combines Apica’s data management expertise in synthetic monitoring and observability with Orson’s advanced test data orchestration capabilities. This integration enables teams to self-service generate comprehensive test data sets derived from production patterns while maintaining compliance with data privacy...

Continue reading

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery Recursion will host an update call today, November 20, 2024 at 7:30 a.m. ET / 5:30 a.m. MT / 12:30 p.m. GMT on LinkedIn, X and YoutubeSALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) — The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion creating a vertically-integrated and technology-enabled drug discovery platform....

Continue reading

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

Additions of ProgenaMatrix® and revyve™ Antimicrobial Wound Gel part of planned expansion of BioStem’s commercial product portfolio POMPANO BEACH, Fla., Nov. 20, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics, today announced the signing of a Letter of Intent (LOI) to acquire commercial-stage products and development technologies from ProgenaCare Global LLC (“ProgenaCare”), a pioneering medical device company leveraging cutting-edge advances in biomaterials to provide effective, affordable advanced wound care solutions. The acquisition of ProgenaMatrix and revyve Antimicrobial Wound Gel reflects the Company’s continued commitment to building a diverse portfolio of complementary wound care...

Continue reading

Pyrogen Testing Market to Surpass Valuation of USD 4.10 Billion by 2031 | SkyQuest Technology

The pyrogen testing market is projected to witness significant growth over the forthcoming years owing to the growing digitalization and automation in testing processes and the expansion of biologics and biopharmaceuticals. Westford, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global pyrogen testing market size will reach a value of USD 4.10 Billion by 2031, with a CAGR of 13.4% during the forecast period (2024-2031). Growing demand for pyrogen testing products in the biotechnology and pharmaceutical industries is one of the key factors driving the expansion of the market. The global pyrogen testing market products is anticipated to increase due to the rapidly expanding pharmaceutical and biotechnology sectors as well as the growing number of innovative treatments being introduced. One of the key elements driving...

Continue reading

Bioremediation Market to Reach USD 31.91 Billion by 2031 | SkyQuest Technology

Rapidly increasing environmental pollution and contamination due to malpractices of humans are projected to primarily augment the demand for bioremediation across the forecast period. Westford, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Bioremediation Market Share will reach a value of USD 31.91 Billion by 2031, with a CAGR of 9.93% during the forecast period (2024-2031). Throughout the projection period, the increasing levels of human wrongdoing-induced environmental contamination and pollution are expected to chiefly augment the demand for bioremediation. The bioremediation market growth is further going to be facilitated by the strict environmental conservation laws implemented and fresh initiatives for restoring the environment and undoing the harms incurred due to human activities during the projection...

Continue reading

CORRECTION – DT Midstream Announces $1.2 Billion Acquisition of Strategic Midwest FERC-Regulated Natural Gas Pipelines

In a release issued under the same headline earlier today by DT Midstream, Inc. (NYSE: DTM), please note that in the “Conference Call” paragraph of the release, the call time should be 9:30 a.m. ET (8:30 a.m. CT) on Wednesday, November 20, rather than 8:00 a.m. ET (7:00 a.m. CT) as previously stated. The corrected release follows: DT Midstream Announces $1.2 Billion Acquisition of Strategic Midwest FERC-Regulated Natural Gas PipelinesThree regulated natural gas transmission pipelines with total capacity of more than 3.7 Bcf/d across the Upper Midwest Premier assets with a high-quality demand-pull customer base Connected to DTM’s existing assets and strategically located to take advantage of strong power demand fundamentalsDETROIT, Nov. 19, 2024 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced that...

Continue reading

Omegro Expands its Presence in the Retail Vertical with the Acquisition of 4R Systems

TORONTO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Today, Omegro announced the acquisition of 4R Systems, a Pennsylvania-based company renowned for its expertise in inventory and supply chain optimization solutions for the retail and consumer goods sectors. 4R Systems specialize in enhancing inventory efficiency and improving overall profitability through cloud-based software. The team leverage their extensive supply chain management expertise and technology to offer comprehensive support to the retail sector, including industry-leading demand planning software. This acquisition presents a significant opportunity for Omegro and 4R to continue delivering high-quality inventory management solutions. Kevin Bradley, Co-CEO of Omegro, expressed confidence in the combined talent of Omegro and 4R, positioning the business for future growth in...

Continue reading

Lesaka to acquire prepaid electricity submetering and payments business Recharger, expanding alternative payments offering

JOHANNESBURG, Nov. 19, 2024 (GLOBE NEWSWIRE) — Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) (“Lesaka” or the “Company”) today announced that it has signed a definitive agreement to acquire 100% of the issued and outstanding ordinary shares of Recharger (Pty) Ltd (“Recharger”), a South African prepaid electricity submetering and payments business. The purchase consideration of ZAR 507 million ($28 million translated at the average exchange rate of $1: ZAR 18.06 as of November 18, 2024) will be paid over two tranches with the first tranche settled at closing and the second tranche a year later. The purchase consideration will be settled through a combination of ZAR 332 million ($18 million) in cash and ZAR 175 million ($10 million) in shares of Lesaka common stock. The share price applied to determine the number of shares of...

Continue reading

DT Midstream Announces $1.2 Billion Acquisition of Strategic Midwest FERC-Regulated Natural Gas Pipelines

Three regulated natural gas transmission pipelines with total capacity of more than 3.7 Bcf/d across the Upper Midwest Premier assets with a high-quality demand-pull customer base Connected to DTM’s existing assets and strategically located to take advantage of strong power demand fundamentalsDETROIT, Nov. 19, 2024 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced that it has reached an agreement to acquire a portfolio of three FERC-regulated natural gas transmission pipelines from ONEOK, Inc. (NYSE: OKE) for $1.2 billion. The pipelines have a total capacity of more than 3.7 Bcf/d with approximately 1,300 miles across seven states in the attractive Midwest market region which is expected to experience continued growth in power demand. The acquisition price represents an approximately 10.5x 2025 EBITDA multiple. Under...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.